Mithra Pharmaceuticals

Tweet this page
<
2022
>
No longer registered as of 17 Dec 2022 - Registration as it was on 13 May 2022
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 997719149208-52

Overview

Lobbying Costs

25,000€ - 49,999€

Financial year: Jan 2020 - Dec 2020

Lobbyists (Full time equivalent)

0.2 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Mithra Pharmaceuticals

    EU Transparency Register

    628472644965-93 First registered on 16 Dec 2021

    Goals / Remit

    Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen Estetrol in a wide range of applications in women health and beyond (e.g. neuroprotection). Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium.

    Main EU files targeted

    • Pharmaceutical Strategy for Europe, with regards to environmentally sustainable pharmaceuticals
    • Strategic Approach to Pharmaceuticals in the Environment, with regards to the effects on and via the environment
    • Biodiversity strategy for 2030, with regards to Zero Pollution in Water
    • Europe's Beating Cancer Plan, with regards to Prevention

    Address

    Head Office
    Rue Saint-Georges 5-7
    Liège 4000
    BELGIUM
    EU Office
    Rue Saint-Georges 5-7
    Liège 4000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    10%2

    Lobbyists (Full time equivalent)

    0.2

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Eucope
    FEAM
    Pharma.be
    Essenscia/bio.be
    Biowin
    Flandersbio

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2020 - Dec 2020

    Lobbying costs for closed financial year

    25,000€ - 49,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    d&d consulting services srl 10,000€ - 24,999€

    Intermediaries for current year

    Name
    d&d consulting services srl

    Closed year Costs

    25,000€ - 49,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Events
    Communication (scientific publications, press releases, social media posts)

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard